152 related articles for article (PubMed ID: 35264873)
1. Significant Biomarkers Identification Associated with Cutaneous Squamous Cell Carcinoma Progression.
Qiu CG; Shen B; Sun XQ
Int J Gen Med; 2022; 15():2347-2360. PubMed ID: 35264873
[TBL] [Abstract][Full Text] [Related]
2. Identification of key genes in cutaneous squamous cell carcinoma: a transcriptome sequencing and bioinformatics profiling study.
Zou DD; Xu D; Deng YY; Wu WJ; Zhang J; Huang L; He L
Ann Transl Med; 2021 Oct; 9(19):1497. PubMed ID: 34805359
[TBL] [Abstract][Full Text] [Related]
3. Seven key hub genes identified by gene co-expression network in cutaneous squamous cell carcinoma.
Chen H; Yang J; Wu W
BMC Cancer; 2021 Jul; 21(1):852. PubMed ID: 34301206
[TBL] [Abstract][Full Text] [Related]
4. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.
Zou DD; Sun YZ; Li XJ; Wu WJ; Xu D; He YT; Qi J; Tu Y; Tang Y; Tu YH; Wang XL; Li X; Lu FY; Huang L; Long H; He L; Li X
Elife; 2023 Dec; 12():. PubMed ID: 38099574
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential gene drivers of cutaneous squamous cell carcinoma: Analysis of microarray data.
Zheng Y; Chi S; Li C
Medicine (Baltimore); 2020 Sep; 99(39):e22257. PubMed ID: 32991423
[TBL] [Abstract][Full Text] [Related]
6. Gene Expression Patterns of Cutaneous Squamous Cell Carcinoma and Actinic Keratosis: Biomarkers Screening for Skin Disease Diagnosis.
Li X; Li Z; Han Z; Zhang L; Liu Z; Liu B
Ann Dermatol; 2018 Oct; 30(5):536-543. PubMed ID: 33911475
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.
Zhang L; Qin H; Wu Z; Chen W; Zhang G
Int J Dermatol; 2018 Oct; 57(10):1208-1217. PubMed ID: 30105812
[TBL] [Abstract][Full Text] [Related]
8. Identification of
Qin S; Yang Y; Zhang HB; Zheng XH; Li HR; Wen J
Transl Cancer Res; 2021 Jan; 10(1):469-478. PubMed ID: 35116276
[TBL] [Abstract][Full Text] [Related]
9. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
[TBL] [Abstract][Full Text] [Related]
10. Identifying an lncRNA-Related ceRNA Network to Reveal Novel Targets for a Cutaneous Squamous Cell Carcinoma.
Xu Y; Dong Y; Deng Y; Qi Q; Wu M; Liang H; She Q; Guo Q
Biology (Basel); 2021 May; 10(5):. PubMed ID: 34068010
[TBL] [Abstract][Full Text] [Related]
11. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.
Peng G; Dan W; Jun W; Junjun Y; Tong R; Baoli Z; Yang X
Tumour Biol; 2015 May; 36(5):3309-17. PubMed ID: 25586346
[TBL] [Abstract][Full Text] [Related]
13. Integrated tissue proteome and metabolome reveal key elements and regulatory pathways in cutaneous squamous cell carcinoma.
Chen W; Rao J; Liu Z; You X; Yuan F; Le F; Tang M; Zhou M; Xie T
J Proteomics; 2021 Sep; 247():104320. PubMed ID: 34237460
[TBL] [Abstract][Full Text] [Related]
14. Screening and expression verification of key genes in cutaneous squamous cell carcinoma.
Huang S; Qin S; Wen J; Zhou Y; Lu Z
Transl Cancer Res; 2022 Jun; 11(6):1730-1739. PubMed ID: 35836527
[TBL] [Abstract][Full Text] [Related]
15. Identification of Metastasis-Associated Genes in Cutaneous Squamous Cell Carcinoma Based on Bioinformatics Analysis and Experimental Validation.
Chen L; Liao X; Jiang X; Yan J; Liang J; Hongwei L
Adv Ther; 2022 Oct; 39(10):4594-4612. PubMed ID: 35947350
[TBL] [Abstract][Full Text] [Related]
16. Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
Riihilä P; Viiklepp K; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Peltonen J; Peltonen S; Kähäri VM
Br J Dermatol; 2020 Mar; 182(3):658-670. PubMed ID: 31049937
[TBL] [Abstract][Full Text] [Related]
17. OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma.
Murata M; Ito T; Tanaka Y; Yamamura K; Furue K; Furue M
J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32106476
[TBL] [Abstract][Full Text] [Related]
18. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
19. Serum Sialylation Changes in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Patients.
Tampa M; Nicolae I; Mitran CI; Mitran MI; Ene C; Matei C; Georgescu SR; Ene CD
J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683168
[TBL] [Abstract][Full Text] [Related]
20. Targeting ESM1/ VEGFα signaling axis: a promising therapeutic avenue for angiogenesis in cervical squamous cell carcinoma.
Li D; Su X; Xue S; Yao L; Yu D; Tang X; Huang Y
J Cancer; 2023; 14(10):1725-1735. PubMed ID: 37476182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
